MetaVia to present DA-1726 trial data at liver symposium in November
Tweet Send to a Friend
MetaVia Inc. (Nasdaq: MTVA) announced that an abstract from its Phase 1 clinical trial of DA-1726 has been accepted for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




